Dactatasvir Tablets

Dactatasvir Tablets

MYDACLA

MYDACLA - It contains Drug / Molecule called “Daclatasvir”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV). It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA

INDICATION:
Mydacla is used for treatment of patients with chronic Hepatitis C.

STRENGTH:
60 mg Tablets.

PACKING :
1* 28 Tablets (Bottle)

STORAGE:
Store at room temperature (25°C), protected from sunlight

MANUFACTURED BY:
Mylan

PRECAUTION & WARNING:

  • Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
  • It should not be used during pregnancy or in women of childbearing potential not using contraception


NATDAC

NATDAC - It is generic / version of “Daklinza”. It contains Drug / Molecule called “Daclatasvir”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV). It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

INDICATION:
It is used for treatment of patients with chronic Hepatitis C.

STRENGTH:
30, 60 mg Tablets.

PACKING :
1* 28 Tablets (Bottle)

STORAGE:
Store at room temperature (25°C), protected from sunlight.

MANUFACTURED BY:
Natco Pharma Ltd.

PRECAUTION & WARNING:
Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate. It should not be used during pregnancy or in women of childbearing potential not using contraception.


DECLAHEP

DACLAHEP- It contains Drug / Molecule called “Daclatasvir”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV). It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

INDICATION:
Daclahep is used for treatment of patients with chronic Hepatitis C.

STRENGTH:
30, 60 mg Tablets.

PACKING :
1* 28 Tablets (Bottle)

STORAGE:
Store at room temperature (25°C), protected from sunlight.

MANUFACTURED BY:
Hetero Healthcare Ltd. (INDIA)

PRECAUTION & WARNING:
Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate. It should not be used during pregnancy or in women of childbearing potential not using contraception.